CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.
Cell Rep
; 17(9): 2367-2381, 2016 11 22.
Article
in En
| MEDLINE
| ID: mdl-27880910
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cyclin-Dependent Kinases
/
Drug Resistance, Neoplasm
/
BRCA1 Protein
/
Triple Negative Breast Neoplasms
/
Poly(ADP-ribose) Polymerase Inhibitors
/
Mutation
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cell Rep
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: